Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

inflammation · Mechanism Report

Does the PLA2G7 rs1051931 GG genotype preserve Lp-PLA2 enzymatic activity?

The GG (Val/Val) genotype of rs1051931 is associated with preserved, higher Lp-PLA2 enzyme activity compared with variant alleles that reduce activity.

SupportedJune 19, 20264 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

The PLA2G7 rs1051931 variant can influence Lp-PLA2 enzyme activity, with the GG genotype generally associated with preserved enzymatic function compared with loss-of-function alleles.

laying out figure…
All 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that the rs1051931 missense change (p.Val379Ala) modulates Lp-PLA2 activity, with the ancestral GG genotype maintaining greater enzymatic function. Mechanistic evidence links the Val379 residue to stability and catalytic efficiency of the enzyme, while each copy of the variant allele produces a modest, additive loss of activity (~2.7% per allele, ~7.2% difference GG vs AA).

Verified conclusion

The PLA2G7 gene encodes lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme primarily associated with LDL particles that plays a dual role in inflammatory signaling and lipid metabolism. The rs1051931 variant (p.Val379Ala) is a well-documented genetic determinant of the variability in this enzyme's activity.

Clinical evidence and enzymatic activity

Large-scale cohort studies and meta-analyses consistently demonstrate that the rs1051931 variant significantly modulates Lp-PLA2 levels. The GG (Val/Val) genotype is the wild-type, ancestral state and is associated with the highest levels of enzymatic activity.

  • Effect of genotype: Individuals with the GG genotype exhibit approximately 7.2% higher Lp-PLA2 activity compared to those with the homozygous variant (AA) genotype.
  • Allelic impact: Each inheritance of the minor allele (A or C, depending on the strand) correlates with a modest, additive reduction in activity, typically estimated at 2.7% per allele ($p < 0.05$ across multiple multi-ethnic cohorts).
  • Population variability: While this variant is a significant predictor of activity in European and multi-ethnic populations, its impact is particularly pronounced in Han Chinese populations, where it shows a strong negative correlation with serum Lp-PLA2 activity as measured by ELISA.

Mechanistic explanations

The rs1051931 polymorphism involves a missense mutation where valine is substituted for alanine at position 379 of the protein sequence.

  • Enzyme stability: The wild-type GG genotype preserves the structural integrity of the serine esterase domain, which is responsible for hydrolyzing proinflammatory mediators like platelet-activating factor (PAF) and oxidized phospholipids.
  • Loss-of-function: The presence of the variant allele represents a partial loss-of-function. While it is less impactful than total loss-of-function mutations (such as Val279Phe), it sufficiently alters the protein's catalytic efficiency or stability to result in lower measurable serum activity.

Bottom line

The PLA2G7 rs1051931 GG genotype is associated with preserved, baseline Lp-PLA2 enzymatic function. In contrast, variant alleles function as modest loss-of-function mutations that predictably decrease enzymatic activity by roughly 2.7% per allele.

References

  1. Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles — academic.oup.com ↗
  2. The Association of PLA2G7 Gene Polymorphisms with Serum Lp-PLA2 Activity and Lipid Profile in Han Chinese Patients with Coronary Heart Disease — dovepress.com ↗
  3. PLA2G7 Genotype, Lipoprotein-Associated Phospholipase A2 Activity, and Coronary Heart Disease Risk in 10 494 Cases and 15 624 Controls of European Ancestry — pmc.ncbi.nlm.nih.gov ↗
  4. Sequencing of Lp-PLA2-encoding PLA2G7 gene in 2000 Europeans reveals several rare loss-of-function mutations — nature.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan hs-CRP reflect low-grade systemic inflammation even within the normal range?→Plausible8 sourcesCan rs1420101 CT, rs20541 AG, and rs1801275 AG contribute to type 2 eosinophilic airway inflammation susceptibility?→